Stock Events

Stock Events

SIGA Technologies 

$5.17
242
-$0.18-3.36% Thursday 03:28

Statistics

Day High
5.17
Day Low
5.17
52W High
-
52W Low
-
Volume
72
Avg. Volume
-
Mkt Cap
370.23M
P/E Ratio
-
Dividend Yield
11.61%
Dividend
0.6

Upcoming

7
APR
Dividend Ex
 
23
APR
Dividend Payment
 
7
APR 27
Dividend Ex
Estimated
 
23
APR 27
Dividend Payment
Estimated
 
7
APR 28
Dividend Ex
Estimated
 

Dividends

11.61%Dividend Yield
Apr 26
$0.6
May 25
$0.6
Apr 24
$0.6
Jun 23
$0.45
Jun 22
$0.45
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
10.06%
1Y Growth
N/A

Earnings

30AprExpected
Q3 2025
Q4 2025
Next
-0.09
-0.09
-0.08
-0.08
Expected EPS
N/A
Actual EPS
N/A

Financials

42.69%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
277.44MRevenue
118.43MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SIGA.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is a major player in the antiviral drug market, offering a range of products that compete with SIGA's portfolio.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.29B
BioMarin Pharmaceutical develops and commercializes innovative biopharmaceuticals, potentially competing in the same therapeutic areas as SIGA.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc, with its broad range of vaccines and antiviral drugs, competes in the same market as SIGA Technologies.
Moderna
MRNA
Mkt Cap10.61B
Moderna Inc is known for its mRNA technology used in vaccines, which could compete with SIGA's treatments in the infectious disease space.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its pharmaceutical division, develops treatments that could compete with SIGA's antiviral and vaccine products.
Novavax
NVAX
Mkt Cap1.36B
Novavax, Inc. focuses on developing vaccines, including for viral infections, which places it in direct competition with SIGA.
Arbutus Biopharma
ABUS
Mkt Cap906.73M
Arbutus Biopharma Corporation works on antiviral therapies and delivery technologies, competing with SIGA in the antiviral space.
Inovio Pharmaceuticals
INO
Mkt Cap124.89M
Inovio Pharmaceuticals, Inc. specializes in DNA medicines, including vaccines for infectious diseases, competing with SIGA's offerings.
Vir Biotechnology
VIR
Mkt Cap827.94M
Vir Biotechnology, Inc. focuses on treating and preventing serious infectious diseases, directly competing with SIGA Technologies in the antiviral market.

About

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
Show more...
CEO
ISIN
US8269171067

Listings

XNAS
US
SIGA
BOATS
BOATS
SIGA.BOATS

0 Comments

Share your thoughts

FAQ

What is SIGA Technologies stock price today?▼
The current price of SIGA.BOATS is $5.17 USD — it has decreased by -3.36% in the past 24 hours. Watch SIGA Technologies stock price performance more closely on the chart.
What is SIGA Technologies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange SIGA Technologies stocks are traded under the ticker SIGA.BOATS.
What is SIGA Technologies market cap?▼
Today SIGA Technologies has the market capitalization of 370.23M
When is the next SIGA Technologies earnings date?▼
SIGA Technologies is going to release the next earnings report on April 30, 2026.
What were SIGA Technologies earnings last quarter?▼
SIGA.BOATS earnings for the last quarter are -0.08 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is SIGA Technologies revenue for the last year?▼
SIGA Technologies revenue for the last year amounts to 277.44M USD.
What is SIGA Technologies net income for the last year?▼
SIGA.BOATS net income for the last year is 118.43M USD.
Does SIGA Technologies pay dividends?▼
Yes, SIGA.BOATS dividends are paid annual. The last dividend per share was 0.6 USD. As of today, Dividend Yield (FWD)% is 11.61%.
When did SIGA Technologies complete a stock split?▼
SIGA Technologies has not had any recent stock splits.